• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高血压患者动态运动期间的血浆神经肽Y

Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension.

作者信息

Pruszczyk P, Chlebus M

机构信息

Department of Hypertension and Angiology, Warsaw Medical Academy, Poland.

出版信息

Clin Exp Hypertens. 1995 Jul;17(5):769-85. doi: 10.3109/10641969509033634.

DOI:10.3109/10641969509033634
PMID:7655447
Abstract

UNLABELLED

The aim or the study was to assess plasma neuropeptide Y immunoreactivity concentration (NPY-ir) during dynamic exercise in pts with different stages of essential hypertension (ESH). We studied 25 males aged 29.4 +/- 6.3 yrs with established ESH (ESH) and 12 healthy males aged 27.3 +/- 5.1 yrs (C). Plasma concentrations of NPY-ir, NA, A, BP were measured before treadmill test, in the last minute of two six-min. work loads corresponding to 60% and 80% of maximal individual load and 30 min. after cessation of exercise. Plasma NPY-ir was evaluated with RIA, NA and A with REA. Gradual exercise resulted in an increase of NPY-ir in ESH (from 14.4 +/- 5.8 to 18.1 +/- 6.4 and 20.7 +/- 8.1 fmol/ml p = 0.036, p = 0.02) and in C (from 11.7 +/- 4.6 to 13.4 +/- 5.0 and 15.2 +/- 5.9 fmol/ml, p < 0.01). Likewise plasma NA and A increased in both groups. Plasma NPY-ir during exercise was significantly higher in ESH than in C (p = 0.041 and p = 0.047) while no such differences were observed in plasma NA and A. According to the left ventricle mass index (LVMI) ESH was divided into two subgroups: with left ventricular hypertrophy (LVH+) n = 10, LVMI = 159.7 +/- 7.7 g/m2 and without the hypertrophy (LVH-) n = 15 LVMI = 112.3 +/- 19.2g/m2. LVH- presented significant increase in plasma NPY-ir during exercise (from 14.7 +/- 5.7 to 18.2 +/- 6.5, 22.8 +/- 8.3 fmol/ml p < 0.01), while no changes in LVH+ were observed (from 14.1 +/- 5.8 to 17.8 +/- 6.0 and 17.8 +/- 6.7 fmol/ml, ns). LVH+ were older than LVH- (33.4 +/- 7.1 yrs vs 26.7 +/- 4.2 p = 0.04), but no correlation between age and plasma NPY-ir was noticed. No differences in plasma NA and A were present between these subgroups.

CONCLUSION

Patients at different stages of essential hypertension display various patterns of sympatho-adrenal activation during dynamic exercise.

摘要

未标记

本研究的目的是评估不同阶段原发性高血压(ESH)患者动态运动期间血浆神经肽Y免疫反应性浓度(NPY-ir)。我们研究了25名年龄在29.4±6.3岁的确诊ESH男性患者(ESH组)和12名年龄在27.3±5.1岁的健康男性(C组)。在跑步机测试前、对应于个体最大负荷60%和80%的两个6分钟工作负荷的最后一分钟以及运动停止后30分钟测量血浆NPY-ir、去甲肾上腺素(NA)、肾上腺素(A)和血压(BP)。血浆NPY-ir用放射免疫分析法(RIA)评估,NA和A用放射酶分析法(REA)评估。逐渐增加运动强度导致ESH组NPY-ir升高(从14.4±5.8升至18.1±6.4和20.7±8.1 fmol/ml,p = 0.036,p = 0.02),C组也升高(从11.7±4.6升至13.4±5.0和15.2±5.9 fmol/ml,p < 0.01)。同样,两组血浆NA和A均升高。运动期间ESH组血浆NPY-ir显著高于C组(p = 0.041和p = 0.047),而血浆NA和A未观察到此类差异。根据左心室质量指数(LVMI),ESH患者分为两个亚组:有左心室肥厚(LVH+)n = 10,LVMI = 159.7±7.7 g/m²;无肥厚(LVH-)n = 15,LVMI = 112.3±19.2 g/m²。LVH-亚组运动期间血浆NPY-ir显著升高(从14.7±5.7升至18.2±6.5、22.8±8.3 fmol/ml,p < 0.01),而LVH+亚组未观察到变化(从14.1±5.8升至17.8±6.0和17.8±6.7 fmol/ml,无显著性差异)。LVH+亚组患者年龄大于LVH-亚组(33.4±7.1岁对26.7±4.2岁,p = 0.04),但未发现年龄与血浆NPY-ir之间存在相关性。这些亚组之间血浆NA和A无差异。

结论

原发性高血压不同阶段的患者在动态运动期间表现出不同模式的交感-肾上腺激活。

相似文献

1
Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension.原发性高血压患者动态运动期间的血浆神经肽Y
Clin Exp Hypertens. 1995 Jul;17(5):769-85. doi: 10.3109/10641969509033634.
2
Hypertensive left ventricular hypertrophy is linked to an enhanced catecholamine response to submaximal exercise.高血压左心室肥厚与次最大运动量运动时儿茶酚胺反应增强有关。
Eur J Clin Invest. 1999 Jul;29(7):594-602. doi: 10.1046/j.1365-2362.1999.00501.x.
3
Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.血浆神经肽Y免疫反应性影响嗜铬细胞瘤患者的左心室质量。
Clin Chim Acta. 2004 Jul;345(1-2):43-7. doi: 10.1016/j.cccn.2004.01.027.
4
Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.人体不同程度交感神经激活过程中的血浆神经肽Y样免疫反应性和儿茶酚胺
Clin Physiol. 1986 Dec;6(6):561-78. doi: 10.1111/j.1475-097x.1986.tb00789.x.
5
Plasma neuropeptide Y and catecholamines in women and men with essential hypertension.原发性高血压患者中血浆神经肽Y和儿茶酚胺水平的性别差异
Blood Press. 1995 May;4(3):143-7. doi: 10.3109/08037059509077586.
6
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.神经肽 Y 受体 Y2 基因多态性与血浆神经肽 Y 水平相互作用,可预测透析患者左心室肥厚。
J Hypertens. 2010 Aug;28(8):1745-51. doi: 10.1097/HJH.0b013e32833bd21b.
7
Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.原发性高血压患者中神经肽Y与α-肾上腺素能受体的相互作用
Mater Med Pol. 1994 Oct-Dec;26(4):127-31.
8
Elevated plasma concentration of neuropeptide Y in adolescents with primary hypertension.原发性高血压青少年血浆神经肽Y浓度升高。
J Hum Hypertens. 1994 May;8(5):345-9.
9
Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects.
Clin Exp Hypertens A. 1989;11 Suppl 1:59-66. doi: 10.3109/10641968909045412.
10
Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise.充血性心力衰竭患者静息及运动时血浆免疫反应性神经肽Y水平
Scand J Clin Lab Invest. 1993 Oct;53(6):569-76.